Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,454 papers from all fields of science
Search
Sign In
Create Free Account
NSC 631570
Known as:
NSC-631570
, NSC631570
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
ukrain
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Introduction of antineoplastic drug NSC631570 in an inpatient and outpatient setting: Comparative evaluation of biological effects
M. Rudyk
,
O. Fedorchuk
,
Y. Susak
,
Yaroslav. W. Nowicky
,
L. Skivka
2016
Corpus ID: 74426146
2015
2015
Physical activity interferes with the immunomodulatory effect of the antineoplastic drug NSC631570.
L. Skivka
,
O. Fedorchuk
,
+4 authors
Yaroslav. W. Nowicky
Current Pharmaceutical Biotechnology
2015
Corpus ID: 25487272
OBJECTIVE The aim of the work was to evaluate the effect of moderate physical exercise on the response of circulating phagocytes…
Expand
2014
2014
The effect of antineoplastic drug NSC631570 on immunogenicity of B16 melanoma
L. Skivka
,
O. Fedorchuk
,
+4 authors
O. Malanchuk
2014
Corpus ID: 53335363
Objectives: NSC631570 is a cytotoxic drug with the ability to be selectively accumulated in tumor tissue and activate apoptosis…
Expand
2013
2013
Antineoplastic drug NSC631570 modulates functions of hypoxic macrophages
L. Skivka
,
O. Fedorchuk
,
+4 authors
J. Nowicky
Cytology and Genetics
2013
Corpus ID: 14920291
Hypoxia is an important factor in the macrophages microenvironment. Many physiological and pathological processes including solid…
Expand
2011
2011
The effect of monotherapy and combined therapy with NSC-631570 (Ukrain) on growth of low- and high-metastasizing B16 melanoma in mice
L. Skivka
,
Y. Susak
,
+4 authors
O. Lykhova
Journal of Oncology Pharmacy Practice
2011
Corpus ID: 24974149
Background. NSC-631570 (Ukrain) is a semisynthetic derivative of the Chelidonium majus alcaloids and the alkylans thiotepa. It…
Expand
2010
2010
The effect of NSC-631570 (ukrain) alone and in combination with pathogen-associated molecules on cell cycle distribution and apoptosis induction of mouse melanoma cells with different biological…
L. Skivka
,
O. Trompak
,
Y. Kudryavets
,
N. Bezdenezhnykh
,
Y. Susak
Experimental oncology
2010
Corpus ID: 20371163
UNLABELLED Monotherapy and combined application of antitumor drug NSC-631570 (Ukrain) are successfully used for treatment of…
Expand
2003
2003
Ukrain (NSC 631570) in combination with locoregional hyperthermia in the treatment of pancreatic cancer with liver metastases: A case report
R. Kleef
2003
Corpus ID: 77951369
A 60-year-old male patient was diagnosed with cancer of the head of the pancreas with metastases to the liver After surgical…
Expand
2000
2000
Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest.
I. Roublevskaia
,
A. Haake
,
B. Polevoda
Drugs under experimental and clinical research
2000
Corpus ID: 22396783
Exposure of ME180 and A431 carcinoma cells to Ukrain (NSC-631570), a semisynthetic compound consisting of alkaloids isolated from…
Expand
2000
2000
Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain.
I. Roublevskaia
,
A. Haake
,
J. Ludlow
,
B. Polevoda
Drugs under experimental and clinical research
2000
Corpus ID: 13299241
Exposure of LNCaP prostate cancer cells to Ukrain (NSC-631570), a novel semisynthetic drug from Chelidonium majus L., results in…
Expand
1996
1996
Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
A. Liepins
,
J. Nowicky
Drugs under experimental and clinical research
1996
Corpus ID: 39960663
Ukrain is a semisynthetic compound consisting of alkaloids from Chelidonium majus L. conjugated to thiophosphoric acid, with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE